(Q30619774)

25 June 2017

1 reference

title

Rizatriptan in acute treatment of migraine: update on new comparative data (English)

1 reference

25 June 2017

1 reference

1

P J Goadsby

1 reference

25 June 2017

language of work or name

English

0 references

publication date

1 January 2000

1 reference

25 June 2017

1 reference

25 June 2017

volume

20 Suppl 1

1 reference

25 June 2017

page(s)

10-15

1 reference

Serotonin 5-HT1B/1D Receptor Agonists in Migraine

25 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2000.020S1010.X

Rizatriptan (MAXALT) for the acute treatment of migraine and migraine recurrence. A placebo-controlled, outpatient study. Rizatriptan 022 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2000.020S1010.X

Efficacy and safety of rizatriptan wafer for the acute treatment of migraine. Rizatriptan Wafer Protocol 049 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2000.020S1010.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2000.020S1010.X

Time-to-event analysis, or who gets better sooner? An emerging concept in headache study methodology

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2000.020S1010.X

Oral rizatriptan versus oral sumatriptan: a direct comparative study in the acute treatment of migraine. Rizatriptan 030 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2000.020S1010.X

Comparison of rizatriptan 10 mg vs. naratriptan 2.5 mg in migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.2000.020S1010.X

10.1046/J.1468-2982.2000.020S1010.X

21 January 2018

Identifiers

DOI

1 reference

25 June 2017

1 reference